The role of corticotropin-releasing factor in pain and analgesia

Pain

Volumn 84, Issue 1, 2000, Pages 1-12

  Lariviere, William R ^a   Melzack, Ronald ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Corticotropin releasing factor; Endogenous pain suppression; Hypothalamic pituitary adrenal axis; Neuroendocrine; Stress

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR;

ANALGESIA; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE FIBER; PAIN; PRIORITY JOURNAL; REVIEW; STRESS;

ANALGESIA; ANIMALS; BETA-ENDORPHIN; BRAIN; CORTICOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; PAIN;

EID: 0033992172     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00193-1     Document Type: Review

References (76)

1. Aldenhoff J.B., Gruol D.L., Rivier J., Vale W., Siggins G.R. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science. 221:1983;875-877.
2. Amit Z., Galina Z.H. Stress-induced analgesia: adaptive pain suppression. Physiol Rev. 66:1986;1091-1120.
3. Avanzino G.L., Ermirio R., Ruggeri P., Cogo C.E. Effect of microelectrophoretically applied corticosterone on raphe neurones in the rat. Neurosci Lett. 50:1984;307-311.
4. Ayesta F.J., Nikolarakis K.E. Peripheral but not intracerebroventricular corticotropin-releasing hormone (CRH) produces antinociception which is not opioid mediated. Brain Res. 503:1989;219-224.
5. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1a, murine IL-1a and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther. 259:1991;988-996.
6. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Ann Rev Neurosci. 7:1984;309-338.
7. Beaulieu S., Di Paolo T., Côté J., Barden N. Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems. Neuroendocrinology. 45:1987;37-46.
8. Besson J.M., Chaouch A. Peripheral and spinal mechanims of nociception. Physiol Rev. 67:1987;67-185.
9. Bianchi M., Panerai A.E. CRH and the noradrenergic system mediate the antinociceptive effect of central interleukin-1α in the rat. Brain Res Bull. 36:1995;113-117.
10. Bianchi M., Sacerdote P., Locatelli L., Mantegazza P., Panerai A.E. Corticotropin releasing hormone, interleukin-1α, and tumor necrosis factor-α share characteristics of stress mediators. Brain Res. 546:1991;139-142.
11. Borsody M.K., Weiss J.M. Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons. Brain Res. 724:1996;149-168.
12. Bouckoms A.J. Limbic surgery for pain. Wall P.D., Melzack R. Textbook of pain. 3rd ed :1994;1171-1187 Churchill Livingstone, Edinburgh.
13. Britton K.T., Morgan J., Rivier J., Vale W., Koob G.F. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology. 86:1985;170-174.
14. Brown M. Corticotropin releasing factor: central nervous system sites of action. Brain Res. 399:1986;10-14.
15. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schäfer M., Loeffler J.P., Stein C. Immune cell-derived β-endorphin: production, release, and control of inflammatory pain in rats. J Clin Invest. 1:1997;142-148.
16. Guide to the care and use of experimental animals. 2nd ed., Vol. 1. 1993;CCAC, Ottawa.
17. Cato A.C., Wade E. Molecular mechanisms of anti-inflammatory actions of glucocorticoids. Bioessays. 18:1996;371-378.
18. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., De Souza E.B. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci. 17:1996;166-172.
19. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci. 6:1986;2908-2914.
20. Chen A.C.N., Treede R.D. The McGill Pain Questionnaire in the assessment of phasic and tonic experimental pain: behavioral evaluation of the 'pain inhibiting pain' effect. Pain. 22:1985;67-79.
21. Chrousos G.P., Gold P.W. The concepts of stress and stress disorders. J Am Med Assoc. 257:1992;1244-1252.
22. Clauw D.J., Chrousos G.P. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation. 4:1997;134-153.
23. Cristea A., Ciobanu A., Stoenescu M., Rusei I. The evolution of the painful sensitivity in acute and chronic stress. Rom J Physiol. 31:1994;75-79.
24. Culman J., Kopin I.J., Saavedra J.M. Regulation of corticotropin-releasing hormone and pituitary-adrenocortical response during acute and repeated stress in the rat. Endocrinol Reg. 25:1991;151-158.
25. Curtis A.L., Pavcovich L.A., Grigoriadis D.E., Valentino R.J. Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus. Neuroscience. 65:1995;541-550.
26. De Souza E.B. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. J Neurosci. 7:1987;88-100.
27. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev. 15:1990;71-100.
28. Ehlers C.L., Henriksen S.J., Wang M., Rivier J., Vale W., Bloom F.E. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rat. Brain Res. 278:1983;332-336.
29. Fuchs P., Cox V.C. Habenula lesions attenuate lateral hypothalamic analgesia in the formalin test. Neuroreport. 4:1993;121-124.
30. Fuchs P.N., Melzack R. Analgesia induced by morphine microinjection into the lateral hypothalamus of the rat. Exp Neurol. 134:1995;277-280.
31. Guillemin R., Vargo T., Rossier J., Minick S., Ling N., Rivier C., Vale W., Bloom F. β-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science. 197:1977;1367-1369.
32. Hargreaves K.M., Mueller G.P., Dubner R., Goldstein D. Dionne. R.A. Corticotropin-releasing factor (CRF) produces analgesia in humans and rats, Brain Res. 422:1987;154-157.
33. Hargreaves K.M., Dubner R., Costello A.H. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur J Pharmacol. 170:1989;275-279.
34. Hargreaves K.M., Flores C.M., Dionne R.A., Mueller G.P. The role of pituitary β-endorphin in mediating corticotropin-releasing factor-induced antinociception. Am J Physiol. 258:(Endocrinol. Metab. 21):1990;E235-E242.
35. Hashimoto K., Murakami K., Takao T., Makino S., Sugawara M., Ota Z. Effect of acute ether or restraint stress on plasma corticotropin-releasing hormone, vasopressin and oxytocin levels in the rat. Acta Med Okayama. 43:1989;161-167.
36. Hsieh J.C., Belfrage M., Stone-Elander S., Hansson P., Ingvar M. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain. 63:1995;225-236.
37. Kiang J.G., Wei E.T. Corticotropin-releasing factor inhibits thermal injury. J Pharmacol Exp Ther. 243:1987;517-520.
38. Kita A., Imano K., Nakamura H. Involvement of corticotropin-releasing factor in the antinociception produced by interleukin-1 in mice. Eur J Pharmacol. 237:1993;317-322.
39. Lariviere W.R., Melzack R. The bee venom test: a new tonic-pain test. Pain. 66:1996;271-277.
40. Linton E.A., McLean C., Nieuwenhuyzen Kruseman A.C., Tilders F.J., Van der Veen E.A., Lowry P.J. Direct measurement of human plasma corticotropin-releasing hormone by 'two-site' immunoradiometric assay. J Clin Endocrinol Metab. 64:1987;1047-1053.
41. MacLennan A.J., Drugan R.C., Hyson R.L., Maier S.F., Madden J.I.V., Barchas J.D. Corticosterone: a critical factor in an opioid form of stress-induced analgesia. Science. 215:1982;1530-1534.
42. Martins J.M., Kastin A.J., Banks W.A. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology. 63:1996;338-348.
43. McKenna J.E., Melzack R. Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain. 49:1992;105-112.
44. Melzack R. Phantom limbs, the self and the brain (the D.O. Hebb memorial lecture). Can Psychol. 30:1989;1-16.
45. Melzack R. Phantom limbs and the concept of a neuromatrix. Trends Neurosci. 13:1990;88-92.
46. Melzack R., Casey K.L. Sensory, motivational and central control determinants of pain: a new conceptual model. Kenshalo D. The skin senses. 1968;423-443 Springfield, IL, Thomas.
47. Melzack R., Wall P.D. The challenge of pain, Updated 2nd ed. 1996;339 Penguin Books, London.
48. Merchenthaler I., Vigh S., Schally A.V., Stumpf W.E., Arimura A. Immunocytochemical localization of corticotropin releasing factor (CRF)like immunoreactivity in the thalamus of the rat. Brain Res. 323:1984;119-122.
49. Monks R. Psychotropic drugs. Wall P.D., Melzack R. Textbook of Pain. 3rd ed. 1994;963-989 Churchill Livingstone, Edinburgh.
50. Mousa S.A., Schäfer M., Mitchell W.M., Hassan A.H.S., Stein C. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol. 311:1996;221-231.
51. Nishioka T., Iyota K., Nakayama T., Suemaru S., Numata Y., Hashimoto K. Effects of ether-laparotomy and water immersion-restraint stress on CRH concentration in the hypothalamus, extrahypothalamic tissues and peripheral blood. Endocrinol J. 40:1993;213-220.
52. Nishioka T., Iyota K., Takao T., Suemaru S., Numata Y., Hashimoto K. Plasma CRH response to water immersion-restraint stress in rats bearing a hypothalamic knife cut. Endocrinol J. 41:1994;453-459.
53. Ono N., Bedran de Castro J.C., McCann S.M. Ultrashort-loop positive feedback of corticotropin(ACTH)-releasing factor to enhance ACTH release in stress. Proc Natl Acad Sci USA. 82:1985;3528-3531.
54. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev. 43:1991;425-473.
55. Poree L.R., Dickenson A.H., Wei E.T. Corticotropin-releasing factor inhibits the response of trigeminal neurons to noxious heat. Brain Res. 502:1989;349-355.
56. Porro C.A., Cavazutti M. Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model. Prog Neurobiol. 41:1993;565-607.
57. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA. 91:1994;8777-8781.
58. Schäfer M., Carter L., Stein C. Interleukin 1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA. 91:1994;4219-4223.
59. Schäfer M., Mousa S.A., Stein C. Corticotropin-releasing factor in antinociception and inflammation. Eur J Pharmacol. 323:1997;1-10.
60. Schäfer M., Mousa S.A., Zhang Q., Carter L., Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA. 93:1996;6096-6100.
61. Sherman J.E., Kalin N.H. ICV-CRH potently affects behavior without altering antinociceptive responding. Life Sci. 39:1986;433-441.
62. Sherman J.E., Kalin N.H. The effects of ICV-CRH on novelty-induced behavior. Pharmacol Biochem Behav. 26:1987;699-703.
63. Sherman J.E., Kalin N.H. ICV-CRH alters stress-induced freezing behaviour without affecting pain sensitivity. Pharmacol Biochem Behav. 30:1988;801-807.
64. Siggins G.R., Gruol D., Aldenhoff J., Pittman Q. Electrophysiological actions of corticotropin-releasing factor in the central nervous system. Fed Proc. 44:1985;237-242.
65. Skofitsch G., Insel T.R., Jacobowitz D.M. Binding sites for corticotropin releasing factor in sensory areas of the rat hindbrain and spinal cord. Brain Res Bull. 15:1985;519-522.
66. Song Z.H., Takemori A.E. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice. J Pharmacol Exp Ther. 254:1990;363-368.
67. Song Z.H., Takemori A.E. Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice. J Pharmacol Exp Ther. 256:1991;909-912.
68. Sumitomo T., Suda T., Tomori N., Yajima F., Nakagami Y., Ushiyama T., Demura H., Shizume K. Immunoreactive corticotropin-releasing factor in rat plasma. Endocrinology. 120:1987;1391-1396.
69. Tojo C., Takao T., Nishioka T., Numata Y., Suemaru S., Hashimoto K. Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus. Endocrinol J. 43:1996;233-239.
70. Truesdell L.S., Bodnar R.J. Reduction in cold-water swim analgesia following hypothalamic paraventricular nucleus lesions. Physiol Behav. 39:1987;727-731.
71. Valentino R.J., Foote S.L. Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology. 45:1987;28-36.
72. Valentino R.J., Foote S.L. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci. 8:1988;1016-1025.
73. Wei E.T., Kiang J.G., Buchan P., Smith T.W. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw. J Pharmacol Exp Ther. 238:1986;783-787.
74. Williams D.W. Jr, Lipton J.M., Giesecke A.H. Jr. Influence of centrally administered peptides on ear withdrawal from heat in the rabbit. Peptides. 7:1986;1095-1100.
75. Wittert G.A., Or H.K., Livesey J.H., Richards A.M., Donald R.A., Espiner E.A. Vasopressin, corticotrophin-releasing factor, and pituitary adrenal responses to acute cold stress in normal humans. J Clin Endocrinol Metab. 75:1992;750-755.
76. Zadina J.E., Kastin A.J. Neonatal peptides affect developing rats: β-endorphin alters nociception and opiate receptors, corticotropin-releasing factor alters corticosterone. Brain Res Dev Brain Res. 29:1986;21-29.